AGILYSYS, INC. financials

AGYS CIK 0000078749

Source: EDGAR filings · Built 2026-06-19T00:25:30Z

Key metrics by reporting period

Up to six most-recent periods side-by-side. Rows are the curated key lines — revenue, margins, cash, debt, equity, cash-flow totals, plus the derived and valuation metrics we compute on top. For every tag a filer reported in one period, use the single-filing drilldown below.

Derived Metrics

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Free Cash Flow 68.15M 52.34M 40.05M 27.22M 27.26M 26.99M
EBITDA 52.60M 30.13M 21.02M 16.39M 10.18M -16.17M
Working Capital 59.02M 12.50M 99.57M 76.14M 64.71M 72.09M
Net Debt -97.85M -26.08M -121.00M -96.10M -86.27M -85.55M
Gross Margin 62.61% 62.40% 60.75% 61.00% 62.43% 65.15%
Operating Margin 13.47% 8.20% 6.63% 6.50% 3.89% -15.28%
Net Margin 12.15% 8.43% 36.30% 7.36% 3.98% -15.31%
Return on Equity (ROE) 11.87% 8.73% 36.45% 13.34% 6.65% -26.29%
Return on Assets (ROA) 8.06% 5.35% 24.60% 6.00% 3.02% -11.06%
Current Ratio 1.47× 1.11× 2.11× 1.97× 1.91× 2.18×
Debt-to-Equity 0.06× 0.18× 0.10× 0.15× 0.11× 0.17×
Effective Tax Rate 19.87% 9.40% -316.72% 7.50% 0.51% 0.98%
Cash Conversion Ratio 1.80× 2.37× 0.56× 2.36× 4.40× -1.35×
Accruals Ratio -0.06× -0.07× 0.11× -0.08× -0.10× -0.26×
SBC % of Revenue 6.83% 6.45% 5.94% 6.54% 8.95% 29.23%
CapEx Coverage 37.88× 19.81× 5.93× 4.76× 23.42× 20.10×
Free Cash Flow Per Share $2.40 $1.85 $1.49 $1.05 $1.07 $1.15

Income Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Revenue from Contract with Customer, Excluding Assessed Tax 319.31M 275.62M 237.46M 198.06M 162.64M 137.18M
Cost of Goods and Services Sold 119.39M 103.64M 93.21M 77.25M 61.10M 47.80M
Gross Profit 199.92M 171.99M 144.26M 120.82M 101.53M 89.38M
Research and Development Expense 72.75M 62.41M 56.74M 50.26M 46.33M 55.34M
Selling, General and Administrative Expense 128.50M 107.94M 95.21M 110.33M
Operating Expenses 156.91M 149.40M 128.50M 107.94M
Operating Income (Loss) 43.02M 22.59M 15.75M 12.88M 6.32M -20.96M
Income Tax Expense (Benefit) 9.62M 2.41M -65.51M 1.18M 33.00K -208.00K
Net Income (Loss) Attributable to Parent 38.79M 23.23M 86.19M 14.58M 6.48M -21.00M
Earnings Per Share, Basic $1.39 $0.84 $3.31 $0.52 $0.19 $-1.01
Weighted Average Number of Shares Outstanding, Basic 27.92M 27.52M 25.67M 24.69M 24.36M 23.46M
Earnings Per Share, Diluted $1.37 $0.82 $3.17 $0.49 $0.18 $-1.01
Weighted Average Number of Shares Outstanding, Diluted 28.39M 28.26M 26.84M 25.93M 25.48M 23.46M

Balance Sheet

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Cash and Cash Equivalents, at Carrying Value 116.89M 73.04M 144.89M 112.84M 96.97M 99.18M
Assets, Current 184.13M 123.53M 188.94M 154.66M 136.17M 133.25M
Assets 481.53M 434.37M 350.43M 243.04M 214.16M 189.87M
Liabilities, Current 125.11M 111.02M 89.37M 78.52M 71.47M 61.16M
Long-term Debt, Excluding Current Maturities 0 24.00M 0
Stockholders' Equity Attributable to Parent 326.79M 265.89M 236.48M 109.31M 97.34M 79.88M
Common Stock, Shares, Outstanding 28.17M 28.02M 27.38M 25.33M 24.73M 24.01M

Cash Flow Statement

Concept FY 2026FY 2025FY 2024FY 2023FY 2022FY 2021
Net Cash Provided by (Used in) Operating Activities 70.00M 55.13M 48.19M 34.46M 28.48M 28.41M
Net Cash Provided by (Used in) Investing Activities -1.85M -148.57M -7.60M -6.87M -25.68M -1.39M
Net Cash Provided by (Used in) Financing Activities -24.47M 21.93M -8.56M -11.09M -4.90M 25.32M

Raw XBRL tagging for a single filing

Every us-gaap and custom concept the filer tagged for one fiscal period, grouped by statement. Start here when a number in the trend table above surprises you and you want to see the exact tag behind it. Derived and valuation rows are omitted here because they already appear in the trend table.

Most recent filing shown by default.

Compare filings side-by-side

Diff any two filings with deltas and added / removed tags.

Immaterial rows are USD line items under 1% of the period's revenue — the noise floor below which a single tag rarely moves the investment thesis. Revenue is read from the filer's top-line concept (Revenues / RevenueFromContractWithCustomerExcludingAssessedTax, with a fallback chain). Non-USD rows, rows without a numeric value, and every row on a filing with no identifiable revenue anchor stay visible. Flip the switch off to see every tag the filer reported for the period.

Loading filing details…

Methodology

All facts on this page come straight from SEC EDGAR XBRL company-facts filings (AGYS CIK 0000078749), grouped by financial statement using FASB's base us-gaap presentation taxonomy. Filers may re-parent concepts onto different statements in their own extension taxonomy, so a handful of rows can show up under a different statement than on the actual 10-K / 10-Q; custom concepts and any we couldn't map fall into Other. Hover a cell to see the fully-qualified concept name and the filer's description.

For the full methodology — statement grouping, the Other bucket, derived metrics, and fact tooltips — see the methodology reference for the statement grouping, the "Other" bucket, derived metrics, and fact tooltips.

Related tickers

PTHS

Pelthos Therapeutics Inc.

ANEB

ANEBULO PHARMACEUTICALS, INC.

GOVB

Gouverneur Bancorp, Inc.